<DOC>
	<DOCNO>NCT00826683</DOCNO>
	<brief_summary>Bone-marrow-derived progenitor cell ( EPCS ) play important role neovascularization tumor growth . In lung cancer , angiogenesis important event mechanism tumor proliferation metastasis . Recent evidence suggest EPCS recruit differentiate mature endothelial cell form new blood vessel . The role EPCs NSCLC unclear . In contrast , angiogenic drug propose combine systemic chemotherapy NSCLC . The aim study identify EPCs peripheral blood patient NSCLC , comparison Chronic Pulmonary Obstructive Disease ( COPD ) , inflammatory disease .</brief_summary>
	<brief_title>Detection Circulating Endothelial Progenitors Cells ( EPCs ) Non-small Cell Lung Cancer ( NSCLC )</brief_title>
	<detailed_description>The aim study study blood circulating level bone-marrow-derived progenitor cell ( EPCS ) . In first phase , EPCs detect healthy non-smokers volunteer validate flow cytometry method ( n=25 ) . In addition , EPC e characterize primary culture analyze EPC-specific marker . In second phase , EPCs detect peripheral blood 50 patient Chronic Obstructive Pulmonary Disease ( COPD ) 50 patient non-small cell lung cancer ( NSCLC ) . Primary culture make confirm EPCS isolation . Methods : EPCs numerate flow cytometry use CD133 , CD146 , CD34 , CD45 VEGFR2 antibody . Primary culture use identify EPCs 5-days culture marker . In addition , BPCO et NSCLC patient , Vascular endothelial cell growth factor ( VEGF ) concentration measure peripheral serum ELISA commercial test . Overall survival analyze NSCLC function initial EPCs concentration . Correlation study initial VEGF serum concentration EPCs level . This study focus possibility EPC determination peripheral blood could use surrogate marker standard antiangiogenic treatment NSCLC .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Signed write consent Subject &gt; 18 year old No precedent therapy cancer Nonsmoker healthy subject current smoker COPD patient NSCLC patient Smallcell lung cancer patient Radiotherapy , chemotherapy target therapy NSCLC</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Non-small cell lung cancer</keyword>
	<keyword>Endothelial cell progenitor</keyword>
	<keyword>Angiogenesis</keyword>
	<keyword>Vascular endothelial cell growth factor</keyword>
	<keyword>Healthy control</keyword>
	<keyword>COPD patient</keyword>
	<keyword>NSCLC patient</keyword>
</DOC>